Dr. RUHI GUNAY

Dr. MEHUL SHAH, Dr. SHREYA SHAH, Dr. DEEKSHA THORAT

Abstract

INTRODUCTION: BRVO IS AN IMPORTANT CAUSE OF MONOOCULAR BLINDNESS FOR WHICH WE WOULD LIKE TO CONDUCT COMPARATIVE STUDY BETWEEN ANTI VEGF AND TRIAMCINOLONE ON CMT

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. CREATION OF FORMAT AND RETRIEVAL OF DATA FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TABULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: COHORT CONSISTED 155 EYES OF 152 PATIENTS 53.3%,46.7% M:F,MEAN AGE 57.4 YEARS,ON PRESENTATION 33.7 % HAD VISION >6/24 AND 41.1 % HAD VISION < 3/60 . POST TREATMENT VISION ON SUBSEQUENT VISITS>6/24 IN 32.5% AND <3/60 IN 21.8% CASES.WHEN WE COMPARED CMT AMONGST ANTI VEGF AND TRIAMCINOLONE GROUP, SIGNIFICANT DIFFERENCE WAS NOTED (P=0.02). CONCLUSION: WE OBSERVED SIGNIFICANT DIFFERENCE ON CMT BETWEEN ANTI VEGF AND TRIAMCINOLONE TREATED PATIENTS FOLLOWING MANAGEMENT OF BRVO. [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP333.pptx" width="100%" height="608"]